Clinical Trial Update: Special Drug Use Investigation for AMERGE® Tablet (Long-term)

View source ↗

Summary

This document reports the completion of a Special Drug Use Investigation evaluating long-term use of AMERGE (naratriptan) tablets for migraine disorders. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• AMERGE (naratriptan hydrochloride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Migraine Disorders | Status: COMPLETED